[3]
Coura, J.R.; Dias, J.C.P. Epidemiology, control and surveillance of Chagas disease - 100 years after its discovery. Mem. Inst. Oswaldo Cruz, 2009, 104(Suppl. 1), 31-40.
[4]
Norman, F.F.; Lopez-Velez, R. Chagas disease and breast-feeding. Emerg. Infect. Dis., 2013, 19, 1561-1566.
[5]
Angheben, A.; Boix, L.; Buonfrate, D.; Gobbi, F.; Bisoffi, Z.; Pupella, S.; Gandini, G.; Aprili, G. Chagas disease and transfusion medicine: a perspective from non-endemic countries. Blood Transfus., 2015, 13, 540-550.
[7]
Coura, J.R.; de Castro, S.L. A critical review on CD chemotherapy. Mem. Inst. Oswaldo Cruz, 2002, 97, 3-24.
[8]
Castro, J.A.; De Mecca, M.M.; Bartel, L.C. Toxic side effects of drugs used to treat CD (American trypanosomiasis). Hum. Exp. Toxicol., 2006, 25, 471-479.
[9]
Jannin, J.; Villa, L. An overview of CD treatment. Mem. Inst. Oswaldo Cruz, 2007, 102(Suppl. 1), 95-97.
[10]
Murta, S.M.F.; Gazzinelli, R.T. Brener, Z.; Romanha, A.J. Molecular
characterization of susceptible and naturally resistant strains
of Trypanosoma cruzi to benznidazole and nifurtimox. Mol. Biol.
Parasitol, 1998, 93, 203-214.
[12]
Machado, F.S.; Tanowitz, H.B.; Teixeira, M.M. New drugs for neglected infectious diseases: Chagas’ disease. Br. J. Pharmacol., 2010, 160, 258-259.
[13]
Silva, B.N.M.; Silva, B.V.; Silva, F.C.; Gonzaga, D.T.; Ferreira, V.F.; Pinto, A.C. Synthesis of novel isatin-type 5′-(4-Alkyl/Aryl-1H-1,2,3-triazoles) via 1,3-dipolar cycloaddition reactions. J. Braz. Chem. Soc., 2013, 24, 1-5.
[14]
Silva, B.N.M.; Pinto, A.C.; Silva, F.C.; Ferreira, V.F.; Silva, B.V. Ultrasound-assisted synthesis of isatin-type 5′-(4-alkyl/aryl-1H-1,2,3-triazoles) via 1,3-dipolar cycloaddition reactions. J. Braz. Chem. Soc., 2016, 27, 2378-2382.
[15]
Chiyanzu, I.; Hansell, E.; Gut, J.; Rosenthal, P.J.; McKerrowb, R.J.; Chibale, K. Synthesis and evaluation of isatins and thiosemicarbazone derivatives against cruzain, falcipain-2 and rhodesain. Bioorg. Med. Chem. Lett., 2003, 13, 3527-3530.
[16]
Guedes, P.M.M.; Urbina, J.A.; Lana, M.; Afonso, L.C.C.; Veloso, V.M.; Tafuri, W.L.; Machado-Coelho, G.L.L.; Chiari, E.; Bahia, M.T. Activity of the new triazole derivative albaconazole against Trypanosoma (Schizotrypanum) cruzi in dog hosts. Antimicrob.
Agents. Chemother., 2004, 48, 4286-4292.
[17]
de Andrade, P.; Galo, O.A.; Carvalho, M.R.; Lopes, C.D.;
Carneiro, Z.A.; Sesti-Costa, R.; de Melo, E.B.; Silva, J.S.;
Carvalho, I. 1,2,3-Triazole-based analogue of benznidazole displays
remarkable activity against Trypanosoma cruzi. Bioorg. Med.
Chem, 2015, 23, 6815-6826.
[18]
Pelosi, G.; Bisceglie, F.; Bignami, F.; Ronzi, P.; Schiavone, P.; Re, M.C.; Casoli, C.; Pilotti, E. Antiretroviral activity of thiosemicarbazone metal complexes. J. Med. Chem., 2010, 53, 8765-8769.
[19]
Parul, N.; Subhangkar, N.; Arun, M. Antimicrobial activity of diferent thiosemicarbazone compounds against microbial pathogens. IRJP, 2012, 3, 350-363.
[20]
Kalinowski, D.S.; Quach, P.; Richardson, D.R. Thiosemicarbazones:
the new wave in cancer treatment. Future Med. Chem, 2009, 1, 1143-1151.
[21]
de Oliveira, R.B.; Souza-Fagundes, E.M.; Soares, R.P.P.; Andrade, A.A.; Krettli, A.U.; Zani, C.L. Synthesis and antimalarial activity of semicarbazone and thiosemicarbazone derivatives. Eur. J. Med. Chem., 2008, 43, 1983-1988.
[22]
Soares, R.O.A.; Echevarria, A.; Bellieny, M.S.; Pinho, R.T.; Leo, R.M.M.; Seguis, W.S.; Machado, G.M.; Canto-Cavalheiro, M.M.; Leon, L.L. Evaluation of thiosemicarbazones and semicarbazones as potential agents anti-Trypanosoma cruzi. Exp. Parasitol., 2011, 129, 381-387.
[23]
Moreira, D.R.M.; Oliveira, A.D.T.; Gomes, P.A.T.M.; Simone, C.A.; Villela, F.S.; Ferreira, R.S.; Silva, A.C.; Santos, T.A.R.; Castro, M.C.A.B.; Pereira, V.R.A.; Leite, A.C.L. Conformational restriction of aryl thiosemicarbazones produces potent and selective anti-Trypanosoma cruzi compounds which induce apoptotic parasite death. Eur. J. Med. Chem., 2014, 75, 467-478.
[24]
Alves, M.A.; Queiroz, A.C.; Alexandre-Moreira, M.S.; Varela, J.; Cerecetto, H.; González, M.; Doriguetto, A.C.; Landre, I.M.; Barreiro, E.J.; Lima, L.M. Design, synthesis and in vitro trypanocidal and leishmanicidal activities of novel semicarbazone derivatives. Eur. J. Med. Chem., 2015, 100, 24-33.
[25]
Silva, B.V.; Silva, B.N.M. Thio- and semicarbazones: Hope in the search for treatment of Leishmaniasis and Chagas disease. Med. Chem., 2017, 13, 110-126.
[26]
Calvet, C.M.; Vieira, D.F.; Choi, J.Y.; Kellar, D.; Cameron, M.D.; Siqueira-Neto, J.L.; Gut, J.; Johnston, J.B.; Lin, L.; Khan, S.; McKerrow, J.H.; Roush, W.R.; Podust, L.M. 4‑Aminopyridyl-based CYP51 inhibitors as anti-Trypanosoma cruzi drug leads with improved pharmacokinetic profile and in vivo potency. J. Med. Chem., 2014, 57, 6989-7005.
[27]
Romanha, A.J.; De Castro, S.L.; Soeiro, M.D.N.C.; Lannes-Vieira, J.; Ribeiro, I.; Talvani, A.; Bourdin, B.; Blum, B.; Olivieri, B.; Zani, C.; Spadafora, C.; Chiari, E.; Chatelain, E.; Chaves, G.; Calzada, J.E.; Bustamante, J.M.; Freitas-Júnior, L.H.; Romero, L.I.; Bahia, M.T.; Lotrowska, M.; Soares, M.; Andrade, S.G.; Armstrong, T.; Degrave, W.; Andrade, Z.A. In vitro and in vivo experimental models for drug screening and development for Chagas disease. Mem. Inst. Oswaldo Cruz, 2010, 105, 233-238.
[28]
Pires, C.L.; Rodrigues, S.D.; Bristot, D.; Gaeta, H.H.; Toyama, D.O.; Farias, W.R.L.; Toyama, M.H. Evaluation of macroalgae sulfated polysaccharides on the Leishmania (L.) amazonensis promastigote. Mar. Drugs, 2013, 11, 934-943.
[29]
Maximiano, F.P.; Costa, G.H.Y.; Souza, J.; Cunha-Filho, M.S.S. Caracterização físico-química do fármaco antichagásico benznidazol. Quim. Nova, 2010, 33, 1714-1719.
[30]
Scholz, F. (Ed.). Electroanalytical methods (Guide to experiments
and applications), 2th ed.; London New York: Springer Heidelberg
Dordrecht, 2009.
[31]
Pérez-Silanes, S.; Devarapally, G.; Torres, E.; Moreno-Viguri, E.; Aldana, I.; Monge, A.; Crawford, P.W. Cyclic voltammetric study of some anti-chagas-active 1,4-dioxidoquinoxalin-2-yl ketone derivatives. Helv. Chim. Acta, 2013, 96, 217-227.
[32]
Tonin, L.T.D.; Barbosa, V.A.; Bocca, C.C.; Ramos, E.R.F.; Nakamura, C.V.; Costa, W.F.; Basso, E.A.B.; Nakamura, T.U.; Sarragioto, M.H. Comparative study of the trypanocidal activity of the methyl 1-nitrophenyl-1,2,3,4-9H-tetrahydro-b-carboline-3-carboxy-late derivatives and benznidazole using theoretical calculations and cyclic voltammetry. Eur. J. Med. Chem., 2009, 44, 1745-1750.
[33]
Fernández, M.; Arce, E.R.; Sarniguet, C.; Morais, T.S.; Tomaz, A.I.; Azar, C.O.; Figueroa, R.; Maya, J.D.; Medeiros, A.; Comini, M.; Garcia, M.H.; Otero, L.; Gambino, D. Novel ruthenium(II) cyclopentadienyl thiosemicarbazone compounds with antiproliferative activity on pathogenic trypanosomatid parasites. J. Inorg. Biochem., 2015, 153, 306-314.
[34]
Oliveira, S.C.B.; Fernandes, I.P.G.; Silva, B.V.; Pinto, A.C.; Oliveira-Brett, A.M. Isatin nitro-derivatives redox behavior. J. Electroanal. Chem., 2013, 689, 207-215.
[35]
Diculescu, V.C.; Kumbhat, S.; Oliveira-Brett, A.M. Electrochemical behaviour of isatin at a glassy carbon electrode. . Anal. Chim. Acta, 2006, 575, 190-197.
[36]
Gupta, A.K.; Sindal, R.S. A comparative study of electrochemical
reduction of isatin and its synthesized Schiff bases at HMDE J.
Chem. Sci, 2009, 121, 347-351.
[37]
Lokesh, S.V.; Satpati, A.K.; Sherigara, B.S. Electrochemical Behavior
of 1,2,4-Triazole and benzotriazole at glassy carbon electrode
in acidic media T. O. Elec. J., 2010, 2, 15-21.
[38]
Pieretti, S.; Haanstra, J.R.; Mazet, M.; Perozzo, R.; Bergamini, C.; Prati, F.; Fato, R.; Lenaz, G.; Capranico, G.; Brun, R.; Bakker, B.M.; Michels, P.A.M.; Scapozza, L.; Bolognesi, M.L.; Cavalli, A. Naphthoquinone derivatives exert their antitrypanosomal activity via a multi-target mechanism. PLoS Negl. Trop. Dis., 2013, 7, e2012.
[39]
Scotti, L. Filho, F.J.; de Moura, R.O Ribeiro, F.F.; Ishiki, H.; da Silva, M.S.; Filho, J.M.; Scotti, M. T. Multi-target drugs for neglected diseases. Curr. Pharm. Des., 2016, 22, 3135-3163.
[40]
Bolognesi, M.L. Multi-target-directed ligands as innovative tools to combat trypanosomatid diseases. Curr. Top. Med. Chem., 2011, 11, 2824-2833.
[41]
Chiyanzu, I.; Hansell, E.; Gut, J.; Rosenthal, P.J.; McKerrow, J.H.; Chibale, K. Synthesis and evaluation of isatins and thiosemicarbazone derivatives against cruzain, falcipain-2 and rhodesain. Bioorg. Med. Chem. Lett., 2003, 13, 3527-3530.
[42]
Scotti, M.T.; Scotti, L.; Ishiki, H.M.; Peron, L.M.; de Rezende, L.; do Amaral, A.T. Variable-selection approaches to generate QSAR models for a set of antichagasic semicarbazones and analogues. Chemom. Intell. Lab. Syst., 2016, 154, 137-149.
[43]
Nagarsenkar, A.; Guntuku, L.; Guggilapu, S.D.; Bai, K.D.; Gannoju, S.; Naidu, V.G.M.; Bathini, N.B. Synthesis and apoptosis inducing studies of triazole linked 3-benzylidene isatin derivatives. Eur. J. Med. Chem., 2016, 124, 782-793.
[44]
Fernicola, S.; Torquati, I.; Paiardini, A.; Giardina, G.; Rampioni, G.; Messina, M.; Leoni, L.; Del Bello, F.; Petrelli, R.; Rinaldo, S.; Cappellacci, L.; Cutruzzolà, F. Synthesis of triazole-linked analogues of c-di-GMP and their interactions with diguanylate cyclase. J. Med. Chem., 2015, 58, 8269-8284.
[45]
Lipeeva, A.V.; Pokrovsky, M.A.; Baev, D.S.; Shakirov, M.M.; Bagryanskaya, I.Y.; Tolstikova, T.G.; Pokrovsky, A.G.; Shults, E.E. Synthesis of 1H-1,2,3-triazole linked aryl(arylamidomethyl)- dihydrofurocoumarin hybrids and analysis of their cytotoxicity. Eur. J. Med. Chem., 2015, 100, 119-128.
[46]
Mareddy, J.; Nallapati, S.B.; Anireddy, J.; Devi, Y.P.; Mangamoori, L.N.; Kapavarapu, R.; Pal, S. Synthesis and biological evaluation of nimesulide based new class of triazole derivatives as potential PDE4B inhibitors against cancer cells. Bioorg. Med. Chem. Lett., 2013, 23, 6721-6727.
[47]
King-Keller, S.; Li, M.; Smith, A.; Zheng, S.; Kaur, G.; Yang, X.; Wang, B.; Docampo, R. Chemical validation of phosphodiesterase C as a chemotherapeutic target in Trypanosoma cruzi, the etiological agent of Chagas’ disease. Antimicrob. Agents Chemother., 2010, 54, 3738-3745.
[48]
Wiggers, H.J.; Rocha, J.R.; Fernandes, W.B.; Sesti-Costa, R.; Carneiro, Z.A.; Cheleski, J.; da Silva, A.B.F.; Juliano, L.; Cezari, M.H.S.; Silva, J.S.; McKerrow, J.H.; Montanari, C.A. Non-peptidic cruzain inhibitors with trypanocidal activity discovered by virtual screening and in vitro assay. PLoS Negl. Trop. Dis., 2013, 7, e2370.
[49]
Wang, H.; Kunz, S.; Chen, G.; Seebeck, T.; Wan, Y.; Robinson, H.; Martinelli, S.; Ke, H. Biological and structural characterization of Trypanosoma cruzi phosphodiesterase C and implications for design of parasite selective inhibitors. J. Biol. Chem., 2012, 287, 11788-11797.
[50]
Kontoyianni, M.; McClellan, L.M.; Sokol, G.S. Evaluation of docking performance: comparative data on docking algorithms. J. Med. Chem., 2004, 47, 558-565.
[51]
Buckner, F.S.; Verlinde, C.L.M.J.; La Flamme, A.C.; Van Voorhis, W.C. Efficient technique for screening drugs for activity against Trypanosoma cruzi using parasites expressing β-galactosidase. Antimicrob. Agents Chemother., 1996, 40, 2592-2597.
[52]
Berman, H.M.; Westbrook, J.; Feng, Z.; Gilliland, G.; Bhat, T.N.; Weissig, H.; Shindyalov, I.N.; Bourne, P.E. The protein data bank. Nucleic Acids Res., 2000, 28, 235-242.
[53]
Dewar, M.J.S. Zoebisch, E.G.; Healy, E.F.; Stewart, J.J.P. AM1: A new general purpose quantum mechanical molecular model. J. Am. Chem. Soc., 1985, 107, 3902-3909.
[54]
Halgren, T.A. Merck molecular force field. I. Basis, form, scope, parameterization and performance of MMFF94. J. Comput. Chem., 1996, 17, 490-519.
[55]
Rocha, G.B.; Freire, R.O.; Simas, A.M.; Stewart, J.J.P. RM1: a reparameterization of AM1 for H, C, N, O, P, S, F, Cl, Br, and I. J. Comput. Chem., 2006, 27, 1101-1111.
[56]
Shao, Y. et al. Advances in methods and algorithms in a modern quantum chemistry program package. Phys. Chem. Chem. Phys., 2006, 8, 3172-3191.
[57]
Morris, G.M.; Huey, R.; Lindstrom, W.; Sanner, M.F.; Belew, R.K.; Goodsell, D.S.; Olson, A.J. AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J. Comput. Chem., 2009, 30, 2785-2791.
[58]
Accelrys Discovery Studio Visualizer (v.3.1) freeware (Accelrys
Software Inc; BIOVIA, San Diego, CA, USA).
Download PDF Flyer